Literature DB >> 6375088

Corneal transplant allograft reaction: possible predisposing factors.

J J Arentsen.   

Abstract

A series of 869 PKs was reviewed to determine the incidence of allograft reactions in the presence or absence of possible predisposing factors. The average follow-up time after PK was 46 months. The possible predisposing factors studied were mild and severe preoperative vascularization, postoperative neovascularization, synechiae, and inflammation. Other factors considered were bilateral grafts, repeat grafts, and recipient's age. Although there was a significantly higher incidence of allograft reactions in the group with possible predisposing factors compared with the group with none of these, a cause-and-effect relationship could not be established for each possible predisposing factor when considered individually. Most of these factors were usually encountered in combinations of two or more, creating a large number of small variables with less statistical significance in predicting first and second reactions. The incidence of second reactions was similar in the presence or absence of these factors, approximately 25%. Only postoperative synechiae and neovascularization had some significance in eventually leading to permanent graft rejection. The incidence of allograft reaction was also similar among patients with repeat grafts and bilateral grafts. There was an insignificant tendency for the incidence of reactions to decrease in older patients, whether possible predisposing factors were present or not. Final visual acuity was comparable between the group having allograft reactions and the total group. The allograft rejection reaction continues to be the most important cause of graft failure. The role of donor-recipient antigen matching was briefly reviewed.

Entities:  

Mesh:

Year:  1983        PMID: 6375088      PMCID: PMC1312459     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  74 in total

1.  Induction of corneal graft rejection by passive cell transfer.

Authors:  A A Khodadoust; A M Silverstein
Journal:  Invest Ophthalmol       Date:  1976-02

2.  UNSUCCESSFUL PENETRATING KERATOPLASTIES. CORRELATION OF CLINICAL AND HISTOLOGIC FINDINGS.

Authors:  R H HALES; W H SPENCER
Journal:  Arch Ophthalmol       Date:  1963-12

3.  Local graft versus host reactions within the anterior chamber of the eye: the formation of corneal endothelial pocks.

Authors:  A A Khodadoust; A M Silverstein
Journal:  Invest Ophthalmol       Date:  1975-09

4.  A systematic method of drawing corneal pathologic conditions.

Authors:  G O Waring; P R Laibson
Journal:  Arch Ophthalmol       Date:  1977-09

5.  Lymphocyte destruction during corneal homograft reaction. A scanning electron microscopic study.

Authors:  F M Polack
Journal:  Arch Ophthalmol       Date:  1973-05

6.  The survival and rejection of epithelium in experimental corneal transplants.

Authors:  A A Khodadoust; A M Silverstein
Journal:  Invest Ophthalmol       Date:  1969-04

7.  Ultramicroscopic changes in the corneal graft stroma during early rejection.

Authors:  A Kanai; F M Polack
Journal:  Invest Ophthalmol       Date:  1971-06

8.  HLA matching and corneal grafting.

Authors:  J R Batchelor; T A Casey; A Werb; D C Gibbs; S S Prasad; D F Lloyd; A James
Journal:  Lancet       Date:  1976-03-13       Impact factor: 79.321

9.  Subepithelial infiltrates: a probable sign of corneal transplant rejection.

Authors:  J H Krachmer; O C Alldredge
Journal:  Arch Ophthalmol       Date:  1978-12

10.  Beneficial effects of histocompatibility in high-risk corneal transplantation.

Authors:  G N Foulks; F Sanfilippo
Journal:  Am J Ophthalmol       Date:  1982-11       Impact factor: 5.258

View more
  16 in total

Review 1.  Bilateral penetrating keratoplasty--indications, results and review of literature.

Authors:  S K Rao; R R Sudhir; R Fogla; R Rajagopal; G Sitalakshmi; P Padmanabhan
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

Review 2.  Immunology of corneal transplantation.

Authors:  W H Constad; K Taraschanskiy
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

3.  A Two-Piece Microkeratome-Assisted Mushroom Keratoplasty Improves the Outcomes and Survival of Grafts Performed in Eyes with Diseased Stroma and Healthy Endothelium (An American Ophthalmological Society Thesis).

Authors:  Massimo Busin; Silvana Madi; Vincenzo Scorcia; Paolo Santorum; Yoav Nahum
Journal:  Trans Am Ophthalmol Soc       Date:  2015

4.  Corneal graft rejection in African Americans at Howard University Hospital.

Authors:  Larry Ferdinand; Vanessa Ngakeng; Robert A Copeland
Journal:  Saudi J Ophthalmol       Date:  2011-04-30

Review 5.  Corneal allograft reaction associated with nonocular inflammation.

Authors:  Gargi Khare Vora; Joseph B Ciolino
Journal:  Digit J Ophthalmol       Date:  2014-05-07

6.  Corneal allograft rejection in bilateral penetrating keratoplasty: clinical and laboratory studies.

Authors:  R F Meyer
Journal:  Trans Am Ophthalmol Soc       Date:  1986

7.  Posterior polymorphous corneal dystrophy: a disease characterized by epithelial-like endothelial cells which influence management and prognosis.

Authors:  J H Krachmer
Journal:  Trans Am Ophthalmol Soc       Date:  1985

8.  Ocular surface rehabilitation: Application of human amniotic membrane in high-risk penetrating keratoplasties.

Authors:  Pho Nguyen; Kelly Rue; Martin Heur; Samuel C Yiu
Journal:  Saudi J Ophthalmol       Date:  2014-07-02

9.  Excimer laser "corneal shaping": a new technique for customized trephination in penetrating keratoplasty. First experimental results in rabbits.

Authors:  Klaus Schmitz; Wolfram Schreiber; Wolfgang Behrens-Baumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-04-17       Impact factor: 3.117

10.  Effects of immunosuppressants after penetrating keratoplasty: meta-analysis of randomized controlled trials.

Authors:  Xin Wei; Xiao-Ming Chen; Lin Wang; Jin-Ping Song; Yin-Ping Deng
Journal:  Int J Ophthalmol       Date:  2011-10-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.